Edgewise Therapeutics

EWTX · NASDAQ

$39.75+$1.83 (+4.83%)TodayMarket closed ·
Prev close $37.92

Who owns EWTX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 63.2% of EWTX’s shares.

  • OrbiMed Advisors, LLC14.4%
  • Paradigm BioCapital Advisors LP9.5%
  • RA Capital Management, LP7.8%
  • Janus Henderson Investors5.6%
  • Next 6 largest institutions25.8%
  • All other shareholders36.8%
Top institutional holders of EWTX
HolderShares% of shares
OrbiMed Advisors, LLC15.52M14.42%
Paradigm BioCapital Advisors LP10.22M9.49%
RA Capital Management, LP8.39M7.80%
Janus Henderson Investors6.08M5.65%
BlackRock Institutional Trust Company, N.A.5.76M5.35%
Novo Holdings A/S5.35M4.97%
Driehaus Capital Management, LLC4.73M4.40%
Perceptive Advisors LLC4.37M4.07%
Vanguard Capital Management, LLC3.86M3.59%
Baker Bros. Advisors LP3.70M3.44%

Largest mutual fund holders

Top mutual fund holders of EWTX
HolderShares% of shares
Vanguard Total Stock Market Index Fund2.91M2.71%
Fidelity Strategic Advisers Fidelity US Total Stk2.81M2.61%
BB Biotech Fd2.78M2.58%
iShares Russell 2000 ETF1.84M1.71%
Vanguard Extended Market Index Fund868.47K0.81%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $11.87M (23 trades) of EWTX on the open market, with no buys.

Latest EWTX insider transactions
InsiderTypeSharesValue
Fox Jonathan CAward308—
Donovan Joanne M.Sale2.92K$126.70K
Russell Alan JAward65.00K—
Derakhshan BehradAward100.00K—
Nofi MichaelAward48.75K—
Donovan Joanne M.Award65.00K—
MOORE JOHN RAward65.00K—
Russell Alan JAward65.00K—
Russell Alan JAward32.50K—
Russell Alan JOption exercise7.03K—

Short interest

Settled Sep 30, 2026

Shares short
11.22M
Days to cover
5.60
% of shares outstanding
10.43%
Average daily volume
2.00M
Change since last report
+17.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.